BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SYH2068 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of SYH2068\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07640217-1078@assetmemo.bio
DTSTAMP:20261121T005700Z
DTSTART;VALUE=DATE:20280330
DTEND;VALUE=DATE:20280331
SUMMARY:SYH2068: Phase 2 readout est. (NCT07640217)
DESCRIPTION:SYH2068\, phase 2\, Atherosclerotic Cardiovascular Disease.\nSt
 udy: A Phase II Clinical Study of SYH2068 Injection in Adults With Elevate
 d Lipoprotein(a)\nEstimated primary completion: 30 March 2028. This is a C
 linicalTrials.gov estimate\, not a confirmed readout date\, and it can mov
 e.\nDrug page: https://assetmemo.bio/drug/syh2068#upcoming-events\nRegistr
 y record: https://clinicaltrials.gov/study/NCT07640217
URL:https://assetmemo.bio/drug/syh2068#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
